Table 11.
Estimated time means and significance of component effects for 100 mg treatment on specific immune responses
| Immune response | Day | Mean | SD | Lower 95% | Upper 95% |
Multivariate Wilks lambda P |
Univariate time P |
Linear component P |
|---|---|---|---|---|---|---|---|---|
| Monocyte phagocytosis | 1 | 37.79 | 2.49 | 30.87 | 44.71 | 0.068 | 0.006 | 0.014 |
| 3 | 42.74 | 3.01 | 34.38 | 51.10 | ||||
| 28 | 50.40 | 3.21 | 41.48 | 59.31 | ||||
| Granulocyte phagocytosis | 1 | 50.92 | 1.98 | 45.42 | 56.42 | 0.125 | 0.147 | 0.038 |
| 3 | 52.46 | 3.70 | 42.19 | 62.72 | ||||
| 28 | 55.85 | 3.43 | 46.333 | 65.37 | ||||
| Production IL-6 | 1 | 20,955.0 | 2409.7 | 14,264.6 | 27,645.4 | 0.177 | 0.032 | 0.061 |
| 3 | 22,108.0 | 2994.5 | 13,794.1 | 30,421.9 | ||||
| 28 | 16,021.6 | 2317.0 | 9588.6 | 22,454.6 |
Abbreviations: IL, interleukin; SD, standard deviation.